青年人中的成年发病型糖尿病13型1例报道

doi:10.6040/j.issn.1671-7554.0.2019.1283

摘要/Abstract

摘要： 目的探讨青年人中的成年发病型糖尿病13型(MODY13)的临床表现、诊断方法及治疗方案。方法完善1例MODY13患者入院后的相关检查,同时行全外显子组检测。结果全外显子组检测结果显示,患者内向整流钾离子通道J家族11因子(KCNJ11)存在变异,调整治疗方案为服用格列美脲能有效改善糖尿病症状。结论 MODY13患者的诊断需借助基因检测,确诊后根据患者年龄使用药物治疗并对饮食进行调控,能够有效控制血糖。

关键词: 青年人中的成年发病型糖尿病13型, 特殊类型糖尿病, 内向整流钾离子通道J家族11因子, 糖尿病, 全外显子组检测, 磺脲类药物

Abstract: Objective To investigate the clinical manifestations, diagnosis and treatment of maturity-onset diabetes of the young13(MODY13). Methods One patient with MODY13 was examined after admission, and whole exome test was performed. Results Whole exome test showed that there was a mutation in potassium channel, inwardly rectifying subfamily J, member 11(KCNJ11). The treatment plan was adjusted. After glimepiride was administered, symptoms of diabetes were effectively improved. Conclusion The diagnosis of MODY13 requires genetic testing. After confirmation, medication and diet should be adjusted according to patients age to control blood glucose.

Key words: Maturity-onset diabetes of the young13, Special type of diabetes, Potassium channel, inwardly rectifying subfamily J, member 11, Diabetes, Whole exome test, Sulfonylureas

中图分类号:

R587

李林童,侯新国,秦君,梁凯,任建民. 青年人中的成年发病型糖尿病13型1例报道[J]. 山东大学学报 (医学版), 2020, 58(6): 71-75.

LI Lintong, HOU Xinguo, QIN Jun, LIANG Kai, REN Jianmin. A case report of maturity-onset diabetes of the young13[J]. Journal of Shandong University (Health Sciences), 2020, 58(6): 71-75.

参考文献

[1] McDonald T, Ellard S. Maturity onset diabetes of the young: identification and diagnosis[J]. Ann Clin Biochem, 2013, 50(5): 403-415.
[2] Gupta MK, Vadde R. A computational structural biology study to understand the impact of mutation on structure-function relationship of inward-rectifier potassium ion channel Kir6.2 in human[J]. J Biomol Struct Dyn, 2020, 1-14. doi:10. 1080/07391102.2020.1733666.
[3] Bowman P, McDonald TJ, Knight BA, et al. Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-KATP-channel pathways[J]. BMJ Open Diabetes Res Care, 2019, 7(1): e000721.
[4] Glotov OS, Serebryakova EA, Turkunova ME, et al. Whole exome sequencing in Russian children with non type 1 diabetes mellitus reveals a wide spectrum of genetic variants in MODY related and unrelated genes[J]. Mol Med Rep, 2019, 20(6): 4905-4914.
[5] 张文博, 刘国良. MODY 13的研究、认识现状及处理[J]. 实用糖尿病杂志, 2017(3): 5-6. ZHANG Wenbo, LIU Guoliang. Research, Cognitive Status and Treatment of MODY 13[J]. Journal of Practical Diabetology, 2017(3): 5-6.
[6] Bonnefond A, Philippe J, Durand E, et al. Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene[J]. PLoS One, 2012, 7(6): e37423.
[7] Siddiqui K, Musambil M, Nazir N. Maturity onset diabetes of the young(MODY)—history, first case reports and recent advances[J]. Gene, 2015, 555(1): 66-71.
[8] Ashcroft FM, Gribble FM. ATP-sensitive K⁺ channels and insulin secretion: their role in health and disease[J]. Diabetologia, 1999, 42(8): 903-919.
[9] Petersmann A, Müller-Wieland D, Müller UA, et al. Definition, classification and diagnosis of diabetes mellitus[J]. Exp Clin Endocrinol Diabetes, 2018, 126(7): 406-410.
[10] Warncke K, Kummer S, Raile K, et al. Frequency and characteristics of MODY 1(HNF4A Mutation)and MODY 5(HNF1B Mutation): analysis from the DPV database[J]. J Clin Endocrinol Metab, 2019, 104(3): 845-855.
[11] Gloyn AL, Pearson ER, Antcliff JF, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes[J]. N Engl J Med, 2004, 350(18): 1838-1849.
[12] Ahmed DM, Abdel Dayem SM, Abdel Kader M, et al. Utilizing the KCNJ11 gene mutations in spotting Egyptian patients with permanent neonatal diabetes who can benefit from treatment shift[J]. Lab Med, 2017, 48(3): 225-229.
[13] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424.
[14] 李秀珍, 刘丽, 盛慧英, 等. 格列本脲治疗新生儿糖尿病4例分析[J].中国实用儿科杂志, 2012, 27(5): 364-367. LI Xiuzhen, LIU Li, SHENG Huiying, et al. Glibenclamide in the treatment of 4 cases of neonatal diabetes[J]. Chinese Journal of Practical Pediatrics, 2012, 27(5): 364-367.
[15] 王晓艳, 陈临琪, 孙辉, 等. 儿童糖尿病基因检测研究进展[J]. 中国实用儿科杂志, 2019, 34(6): 523-526. WANG Xiaoyan, CHEN Linqi, SUN Hui, et al. Research progress of genetic testing for childhood diabetes[J]. Chinese Journal of Practical Pediatrics, 2019, 34(6): 523-526.
[16] 张丽娜, 郭立新. 磺脲类降糖药物的临床认识[J]. 中国实用内科杂志, 2014, 34(10): 969-973. ZHANG Lina, GUO Lixin. Clinical knowledge of sulfonylurea hypoglycemic drugs[J]. Chinese Journal of Practical Internal Medicine, 2014, 34(10): 969-973.
[17] Shepherd H, Shields M, Hudson M, et al. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin[J]. Diabetologia, 2018, 61(12): 2520-2527.
[18] Piccolo R, Franzone A, Koskinas KC, et al. Effect of diabetes mellitus on frequency of adverse events in patients with acute coronary syndromes undergoing percutaneous coronary intervention[J]. Am J Cardiol, 2016, 118(3): 345-352.
[19] Dallali H, Pezzilli S, Hechmi M, et al. Genetic characterization of suspected MODY patients in Tunisia by targeted next-generation sequencing[J]. Acta Diabetol, 2019, 56(5): 515-523.
[20] Ming-Qiang Z, Yang-Li D, Ke H, et al. Maturity onset diabetes of the young(MODY)in Chinese children: genes and clinical phenotypes[J]. J Pediatr Endocrinol Metab, 2019, 32(7): 759-765.
[21] Bowman P, Sulen Å, Barbetti F, et al. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study[J]. Lancet Diabetes Endocrinol, 2018, 6(8): 637-646.

相关文章 15

[1]	孟晓梅,郝亚平,王亮,于晓,唐与晓. 血清Isthmin1、Gremlin2水平与2型糖尿病患者视网膜病变的相关性[J]. 山东大学学报 (医学版), 2025, 63(9): 102-107.
[2]	王梦星,薛付忠,杨帆. 基于多模态交叉注意力机制融合的1型糖尿病血糖浓度预测方法[J]. 山东大学学报 (医学版), 2025, 63(8): 41-50.
[3]	申路佳,逯天威,巩伟明,赵岩松,王淑康,袁中尚. 代谢风险评分在2型糖尿病人群心血管结局预测中的应用[J]. 山东大学学报 (医学版), 2025, 63(8): 69-78.
[4]	陈莹莹,王鲁,胡锡峰,朱高培,薛付忠. 基于贝叶斯网络的2型糖尿病患者并发脑卒中风险预测[J]. 山东大学学报 (医学版), 2025, 63(8): 94-102.
[5]	陈绪军, 何国伟. 着力进一步推进动脉桥在我国冠心病冠脉旁路移植术中的应用[J]. 山东大学学报 (医学版), 2025, 63(5): 1-5.
[6]	卢圣勋,邢亚闯,罗俊辉,刘杰,何厚乐,王志强,张娜. 糖尿病患者冠脉旁路移植手术中动脉桥的研究现状[J]. 山东大学学报 (医学版), 2025, 63(5): 33-39.
[7]	杜学识,倪向敏,梁馨予,白倩,朱文艺,王建. 雌马酚对DN的保护作用及潜在靶点[J]. 山东大学学报 (医学版), 2024, 62(8): 49-58.
[8]	许沛晨,李晓博,庄向华,娄能俊,吕丽,周玲雁,牟亚朋,宋玉文,陈诗鸿. 儿童Alstrom综合征2例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(3): 107-111.
[9]	林晓倩,封茂燕,牟正. 二肽基肽酶-4抑制剂的药学特点及临床应用[J]. 山东大学学报 (医学版), 2024, 62(12): 43-48.
[10]	于丹凤,曹娟,于世佳,杜鲁涛,侯新国. 电化学发光法与液相色谱-串联质谱法评估糖尿病患者维生素D缺乏程度的效能比较与界值确定[J]. 山东大学学报 (医学版), 2023, 61(7): 90-95.
[11]	李金泉,高美芳,闫飞,董明. 136例2型糖尿病患者肌肉痉挛的发生频率及危险因素[J]. 山东大学学报 (医学版), 2023, 61(5): 20-24.
[12]	张天鑫,张婷,黄鑫,韩佳沂,王淑康. 氨基酸与2型糖尿病因果关系的孟德尔随机化分析[J]. 山东大学学报 (医学版), 2023, 61(5): 102-107.
[13]	黄珊,娄能俊,韩晓琳,梁中昊,华梦羽,庄向华,陈诗鸿. 高糖环境下Lipin1对神经元代谢组学的影响[J]. 山东大学学报 (医学版), 2023, 61(2): 1-8.
[14]	包瑾瑾,刘庆燕,孙甜甜,陈青,刘佳. 糖尿病相关抗体阳性合并MODY14相关APPL1基因突变1例[J]. 山东大学学报 (医学版), 2023, 61(12): 113-118.
[15]	韩梅,孟维静,陶子琨,杨希,徐雅琪,穆华夏,卜伟晓,王素珍,石福艳. 基于G-计算的高血压、抑郁在2型糖尿病与认知功能之间的因果多中介分析[J]. 山东大学学报 (医学版), 2023, 61(10): 101-108.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed